Taysha's Rett Syndrome Gene Therapy TSHA|102 Continues to ...

Taysha's Rett Syndrome Gene Therapy TSHA-102 Continues to ...

Taysha's Rett Syndrome Gene Therapy TSHA-102 Continues to Show Promise in Adult and Pediatric Patients ... Various improvements were seen in 2 ...

Taysha Gene Therapies Announces Positive Clinical Data Across ...

TSHA-102 is a self-complementary intrathecally delivered AAV9 investigational gene transfer therapy in clinical evaluation for Rett syndrome.

Taysha Gene Therapies Announces Oral Presentation on TSHA-102 ...

Its lead clinical program TSHA-102 is in development for Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying ...

Taysha Gene Therapies Doses First Pediatric Patient in U.S. Gene ...

Today's announcement marks another exciting milestone for our Rett syndrome community as two companies are now actively dosing adult and ...

Rett gene therapy TSHA-102 showing early safety, benefits in trials

TSHA-102, an experimental gene therapy for Rett syndrome, appears to ... mutation, its developer, Taysha Gene Therapies, reported.

Phase 1/2 Studies Highlight Durable Impacts of Gene Therapy ...

Initial data from a few pediatric and adult patients with Rett syndrome showed that treatment with TSHA-102 resulted in numerous positive ...

Taysha Gene Therapies Updates Community on Positive Initial ...

The U.S. FDA cleared Taysha's Investigational New Drug (IND) application for TSHA-102 in pediatric patients with Rett syndrome. The first U.S. ...

Taysha's Rett Syndrome Gene Therapy Gets RMAT Designation

The FDA has granted Regenerative Medicine Advanced Therapy (RMAT) Designation to Taysha Gene Therapies' TSHA-102 gene therapy program for treating Rett ...

Taysha Gene Therapies Announces Oral Presentation on TSHA-102 ...

TSHA-102 is a self-complementary intrathecally delivered AAV9 investigational gene transfer therapy in clinical evaluation for Rett syndrome.

Taysha Doses Second Patient With Rett Syndrome With TSHA-102 ...

Taysha has stated that the FDA has cleared its investigational new drug application for the gene therapy to be assessed in pediatric patients ...

FDA grants RMAT designation to Taysha's Rett syndrome gene ...

Taysha Gene Therapies has received a regenerative medicine advanced therapy (RMAT) designation for its gene therapy candidate TSHA-102 from the US Food and ...

Taysha Announces First Patient Dosed with Gene Therapy

Taysha Gene Therapies announced today that the first Rett syndrome patient has been dosed with the investigational gene therapy, TSHA-102, in a clinical trial ...

FDA moves to support TSHA-102, potential Rett gene therapy

“We believe receiving RMAT designation reinforces the high unmet medical need in Rett syndrome and the therapeutic potential of TSHA-102 to ...

Taysha Gene Therapies Announces Positive Clinical Data Across ...

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 ...

Taysha Shares Positive Rett Results in Bid to Move Past Roadblocks

Taysha Gene Therapies touted positive early-stage data last month for its gene therapy to treat Rett syndrome, which has become the company's main focus.

Taysha links gene therapy to motor gains in small Rett study

Taysha Gene Therapies has unfurled more data in the developmental disorder Rett syndrome, linking its gene therapy to improvements in the first adults and ...

Taysha Cleared to Dose Second Patient in Gene Therapy Trial

Taysha Gene Therapies recently dosed the first patient in their Rett syndrome gene therapy trial ... TSHA-102 gene therapy. A letter from ...

Taysha Gene Therapy Clinical Trial Cleared by Health Canada

TSHA-102 is designed to deliver a functional MECP2 gene to the brain in patients with Rett syndrome using a novel technology platform, called ...

Second Patient Dosing Recommended for TSHA-102 Gene Therapy ...

... -based gene therapy for Rett syndrome, Taysha Gene Therapies was recommended to continue with investigating the therapy in a second patient.

Clinical Trials Archives - Page 3 of 5

Taysha Announces First Patient Dosed with Gene Therapy · A First for Rett: FDA Approves Trofinetide for Treatment of Rett Syndrome! · Taysha Gene Therapies ...